Exact outline of melanoma could lead to new diagnostic tools, therapies

May 8, 2014, Oregon State University
New research has outlined the exact process by which UVB radiation from the sun can cause melanoma. Credit: Oregon State University

Researchers at Oregon State University have identified a specific biochemical process that can cause normal and healthy skin cells to transform into cancerous melanoma cells, which should help predict melanoma vulnerability and could also lead to future therapies.

More than 70,000 cases of melanoma, the deadliest form of , develop in the U.S. every year.

The work was published today in PLoS Genetics, in work supported by the National Institutes of Health.

"We believe this is a breakthrough in understanding exactly what leads to cancer formation in melanoma," said Arup Indra, an associate professor in the OSU College of Pharmacy. "We've found that some of the mechanisms which ordinarily prevent cancer are being switched around and actually help promote it.

"In melanoma, the immune system is getting thrown into reverse," he said. "Immune cells that previously were attracted to help deal with a problem are instead repulsed."

The key to this process, the researchers said, is a protein called retinoid-X-receptor, or RXR. When present in an adequate amount, the RXR protein aids the proper operation of the immune response in the skin. Primary players in this are called , which produce protective pigments, or melanin, in response to exposure to ultraviolet radiation in sunlight – in simple terms, a suntan.

Even with this protection, however, both melanocytes and other skin cells called keratinocytes routinely suffer genetic damage. Sometimes the damage can be repaired, and at other times the – in the presence of adequate levels of RXR in the melanocytes – will kill the defective skin cells before they become malignant.

When expressed levels of RXR are too low in the melanocytes, however, this protective process breaks down. The chemicals that can help control mutated cells are actually suppressed, and the conditions for cancer promoted. DNA-mutated melanocytes begin to thrive at the same time other skin cells die and free up space for the growing, mutating melanocytes. The ultimate result can be the malignancy known as melanoma, which in turn can spread from the skin throughout the body.

"When there isn't enough RXR, the melanocytes that exist to help shield against cancer ultimately become part of the problem," Indra said. "It's routine to have from sunlight, because normally those cells can be repaired or killed if necessary. It's the breakdown of these control processes that result in , and that happens when RXR levels get too low."

This process has not before been outlined in its entirety, Indra said, and the new findings open several possibilities. One would be a diagnostic test to determine when RXR levels are lower than they should be – which would set the stage for and possibly other cancers, but also with careful monitoring facilitate earlier diagnosis.

Beyond that, mechanisms may be developed to stabilize or stimulate the levels of RXR expression, and form the basis for a therapy. This might be done through diet or a "nanocarrier" drug that could deliver RXR to cells, Indra said.

"It's quite possible that a new and effective therapy can now be developed, based on increasing levels of RXR," Indra said.

Explore further: A method for the diagnosis and prognosis of melanoma, the most aggressive skin cancer, is patented

Related Stories

A method for the diagnosis and prognosis of melanoma, the most aggressive skin cancer, is patented

February 19, 2014
UPV/EHU researchers have developed a method for the diagnosis and prognosis of cutaneous melanoma, the type of skin cancer with the highest mortality rate.This method will help not only in the more effective early detection ...

Protecting the skin from sun exposure

January 27, 2014
The ultraviolet radiation (UVR) present in sunlight is the most common environmental carcinogen, and long-term exposure to UVR can lead to skin cancer and premature aging of the skin. To develop better methods of protection ...

Scent of melanoma: New research may lead to early non-invasive detection and diagnosis

June 13, 2013
According to new research from the Monell Center and collaborating institutions, odors from human skin cells can be used to identify melanoma, the deadliest form of skin cancer. In addition to detecting a unique odor signature ...

Fast-acting virus targets melanoma in mice

June 17, 2013
(Medical Xpress)—Yale researchers eradicated most melanoma tumors by exposing them to a fast-acting virus, they report in the June 15 edition of the Journal of Virology.

Recommended for you

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.